TYMS and neoplasm: To study whether reduction of TYMS level would sensitize tumor cells to the antimetabolite chemotherapy agents pemetrexed or gemcitabine, we transiently transduced Luc-hTS5278 cells with lentiviral 10 MOI TS shRNA #61, #64 or NS shRNA and then treated cells with increasing concentrations of either drug.